Fiona Yull

Last active: 3/31/2020

  1. Use of bioluminescent imaging to investigate the role of nuclear factor-kappaBeta in experimental non-small cell lung cancer metastasis. Stathopoulos GT, Sherrill TP, Han W, Sadikot RT, Polosukhin VV, Fingleton B, Yull FE, Blackwell TS (2008) Clin Exp Metastasis 25(1): 43-51
    › Primary publication · 18008176 (PubMed)
  2. The nuclear factor kappa-B pathway in airway epithelium regulates neutrophil recruitment and host defence following Pseudomonas aeruginosa infection. Chen SM, Cheng DS, Williams BJ, Sherrill TP, Han W, Chont M, Saint-Jean L, Christman JW, Sadikot RT, Yull FE, Blackwell TS (2008) Clin Exp Immunol 153(3): 420-8
    › Primary publication · 18647324 (PubMed) · PMC2527362 (PubMed Central)
  3. The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth. Jin RJ, Lho Y, Connelly L, Wang Y, Yu X, Saint Jean L, Case TC, Ellwood-Yen K, Sawyers CL, Bhowmick NA, Blackwell TS, Yull FE, Matusik RJ (2008) Cancer Res 68(16): 6762-9
    › Primary publication · 18701501 (PubMed) · PMC2840631 (PubMed Central)
  4. Host nuclear factor-kappaB activation potentiates lung cancer metastasis. Stathopoulos GT, Sherrill TP, Han W, Sadikot RT, Yull FE, Blackwell TS, Fingleton B (2008) Mol Cancer Res 6(3): 364-71
    › Primary publication · 18337446 (PubMed)
  5. Epithelial NF-kappaB activation promotes urethane-induced lung carcinogenesis. Stathopoulos GT, Sherrill TP, Cheng DS, Scoggins RM, Han W, Polosukhin VV, Connelly L, Yull FE, Fingleton B, Blackwell TS (2007) Proc Natl Acad Sci U S A 104(47): 18514-9
    › Primary publication · 18000061 (PubMed) · PMC2141808 (PubMed Central)
  6. Conditional regulation of cyclooxygenase-2 in tracheobronchial epithelial cells modulates pulmonary immunity. Park GY, Hu N, Wang X, Sadikot RT, Yull FE, Joo M, Peebles RS, Blackwell TS, Christman JW (2007) Clin Exp Immunol 150(2): 245-54
    › Primary publication · 17672868 (PubMed) · PMC2219354 (PubMed Central)
  7. A transgenic model reveals important roles for the NF-kappa B alternative pathway (p100/p52) in mammary development and links to tumorigenesis. Connelly L, Robinson-Benion C, Chont M, Saint-Jean L, Li H, Polosukhin VV, Blackwell TS, Yull FE (2007) J Biol Chem 282(13): 10028-35
    › Primary publication · 17261585 (PubMed)
  8. Airway epithelium controls lung inflammation and injury through the NF-kappa B pathway. Cheng DS, Han W, Chen SM, Sherrill TP, Chont M, Park GY, Sheller JR, Polosukhin VV, Christman JW, Yull FE, Blackwell TS (2007) J Immunol 178(10): 6504-13
    › Primary publication · 17475880 (PubMed)
  9. Targeted immunomodulation of the NF-kappaB pathway in airway epithelium impacts host defense against Pseudomonas aeruginosa. Sadikot RT, Zeng H, Joo M, Everhart MB, Sherrill TP, Li B, Cheng DS, Yull FE, Christman JW, Blackwell TS (2006) J Immunol 176(8): 4923-30
    › Primary publication · 16585588 (PubMed)
  10. Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases. Stafforini DM, Sheller JR, Blackwell TS, Sapirstein A, Yull FE, McIntyre TM, Bonventre JV, Prescott SM, Roberts LJ (2006) J Biol Chem 281(8): 4616-23
    › Primary publication · 16371369 (PubMed)